OAM
IDXX icon

Ostrum Asset Management’s Idexx Laboratories IDXX Stock Holding History

Ostrum Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Sell
1,539
-502
-25% -$282K 0.04% 253
2026
Q1 		$1.15M Buy
2,041
+976
+92% +$626K 0.06% 206
2025
Q4 		$721K Sell
1,065
-136
-11% -$92.6K 0.03% 330
2025
Q3 		$767K Sell
1,201
-94
-7% -$57.1K 0.03% 353
2025
Q2 		$695K Sell
1,295
-20
-2% -$9.56K 0.03% 371
2025
Q1 		$552K Sell
1,315
-169
-11% -$73.4K 0.03% 400
2024
Q4 		$614K Sell
1,484
-528
-26% -$232K 0.05% 375
2024
Q3 		$1.02M Sell
2,012
-32
-2% -$15.5K 0.08% 306
2024
Q2 		$996K Sell
2,044
-29
-1% -$14.6K 0.09% 301
2024
Q1 		$1.12M Buy
2,073
+617
+42% +$337K 0.09% 327
2023
Q4 		$808K Buy
1,456
+598
+70% +$281K 0.07% 353
2023
Q3 		$375K Sell
858
-1,229
-59% -$613K 0.03% 487
2023
Q2 		$1.05M Buy
2,087
+3
+0.1% +$1.44K 0.09% 310
2023
Q1 		$1.04M Buy
+2,084
New +$997K 0.09% 298

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ostrum Asset Management's IDXX Position: Q2 2026 in Review

Ostrum Asset Management reduced its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, selling an estimated $282K and leaving 1,539 shares worth $810K. The position accounts for 0.04% of the portfolio, ranked #253.

Ostrum Asset Management first reported a position in IDXX in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.15M in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ostrum Asset Management held 1,539 shares of Idexx Laboratories worth $810K as of Q2 2026.
  • Ostrum Asset Management sold 502 Idexx Laboratories shares in Q2 2026, an estimated $282K.
  • Idexx Laboratories made up 0.04% of Ostrum Asset Management's portfolio in Q2 2026, its #253 holding.
  • Ostrum Asset Management first reported a position in Idexx Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Ostrum Asset Management's Idexx Laboratories position peaked at $1.15M in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.